BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34565365)

  • 21. Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice.
    Li Z; Liu J; Li J; Kong Y; Sandusky G; Rao X; Liu Y; Wan J; Liu X
    J Biol Chem; 2017 Oct; 292(42):17461-17472. PubMed ID: 28900036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.
    Jang YJ; Ji JH; Choi YC; Ryu CJ; Ko SY
    J Biol Chem; 2007 Jan; 282(4):2473-82. PubMed ID: 17121863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
    Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
    Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
    Li X; Jiang F; Ge Z; Chen B; Yu J; Xin M; Wang J; An L; Wei J; Wu L
    Dig Dis Sci; 2019 Nov; 64(11):3215-3227. PubMed ID: 31041640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
    Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications.
    Armstrong SA; Schultz CW; Azimi-Sadjadi A; Brody JR; Pishvaian MJ
    Mol Cancer Ther; 2019 Nov; 18(11):1899-1908. PubMed ID: 31676541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle.
    Albahde MAH; Zhang P; Zhang Q; Li G; Wang W
    Front Oncol; 2020; 10():49. PubMed ID: 32117719
    [No Abstract]   [Full Text] [Related]  

  • 28. Polo-like kinase 1 inhibits DNA damage response during mitosis.
    Benada J; Burdová K; Lidak T; von Morgen P; Macurek L
    Cell Cycle; 2015; 14(2):219-31. PubMed ID: 25607646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
    Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
    PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival.
    Chang YC; Chiou J; Yang YF; Su CY; Lin YF; Yang CN; Lu PJ; Huang MS; Yang CJ; Hsiao M
    Cancer Res; 2019 Sep; 79(18):4754-4766. PubMed ID: 31358528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin promotes proliferation of pancreatic ductal epithelial cells by increasing expression of PLK1 through PI3K/AKT and NF-κB pathway.
    Wu K; Wang W; Chen H; Gao W; Yu C
    Biochem Biophys Res Commun; 2019 Feb; 509(4):925-930. PubMed ID: 30642632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homoharringtonine inhibits melanoma cells proliferation in vitro and vivo by inducing DNA damage, apoptosis, and G2/M cell cycle arrest.
    Tang JF; Li GL; Zhang T; Du YM; Huang SY; Ran JH; Li J; Chen DL
    Arch Biochem Biophys; 2021 Mar; 700():108774. PubMed ID: 33548212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RO3280: A Novel PLK1 Inhibitor, Suppressed the Proliferation of MCF-7 Breast Cancer Cells Through the Induction of Cell Cycle Arrest at G2/M Point.
    Ergul M; Bakar-Ates F
    Anticancer Agents Med Chem; 2019; 19(15):1846-1854. PubMed ID: 31244432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells.
    Agarwal C; Tyagi A; Agarwal R
    Mol Cancer Ther; 2006 Dec; 5(12):3294-302. PubMed ID: 17172433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation.
    Ding G; Xu X; Li D; Chen Y; Wang W; Ping D; Jia S; Cao L
    Cell Death Dis; 2020 Oct; 11(10):893. PubMed ID: 33093461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
    Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
    Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA damage response and repair in pancreatic cancer development and therapy.
    Rahnamay Farnood P; Danesh Pazhooh R; Asemi Z; Yousefi B
    DNA Repair (Amst); 2021 Jul; 103():103116. PubMed ID: 33882393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.